跳至主要内容
临床试验/JPRN-UMIN000012831
JPRN-UMIN000012831招募中未知

To evaluate the relationships between the serum concentration of Erlotinib and the effects and toxicities of them - To evaluate the relationships between the serum concentration of Erlotinib and the effects and toxicities of them

agasaki Thoracic Oncology Group0 个研究点目标入组 20 人开始时间: 2014年1月12日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) severe cardiac effusion 2) severe SVC syndrome 3) severe complications 4) severe cardiac diseases 5) severe diabetes mellitus or hypertension 6) severe infections 7) Interstitial pneumonia or pulmonary fibrosis on chest CT scans 8)history of drug allergy 9)pregnant or or lactating women or those who declined contraception 10)those judged not suitable by the attending physician

研究者

发起方
agasaki Thoracic Oncology Group

相似试验